- Conditions
- PFAS, Environmental Exposures, Occupational Exposure to Chemicals, Military Exposure, Burn Pit Exposure, Forever Chemicals, Hyperlipidemias, Hypercholesterolemia, Mixed Dyslipidemia, Hyperlipidemia (E.G., Hypercholesterolemia)
- Interventions
- Colesevelam, Placebo
- Drug
- Lead sponsor
- University of Rhode Island
- Other
- Eligibility
- 25 Years to 65 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2029
- U.S. locations
- 2
- States / cities
- Louisville, Kentucky • Augusta, Maine
Source: ClinicalTrials.gov public record
Updated May 17, 2026 · Synced May 22, 2026, 1:09 AM EDT